Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | +5.72% | -0.00% | -35.15% |
Mar. 28 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Financials (USD)
Sales 2024 * | 6.22M | Sales 2025 * | 8M | Capitalization | 2.77M |
---|---|---|---|---|---|
Net income 2024 * | -10M | Net income 2025 * | -8M | EV / Sales 2024 * | 0.44 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.35 x |
P/E ratio 2024 * |
-0.34
x | P/E ratio 2025 * |
-0.42
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.4% |
Latest transcript on Arcadia Biosciences, Inc.
1 day | +5.72% | ||
1 week | -0.00% | ||
Current month | -8.15% | ||
1 month | -17.82% | ||
3 months | -20.71% | ||
6 months | -35.76% | ||
Current year | -35.15% |
Managers | Title | Age | Since |
---|---|---|---|
Stanley Jacot
CEO | Chief Executive Officer | 54 | 22-02-01 |
Thomas Schaefer
DFI | Director of Finance/CFO | 48 | 20-06-30 |
Kevin Comcowich
CHM | Chairman | 55 | 16-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Amy Yoder
BRD | Director/Board Member | 56 | 17-08-09 |
Gregory Waller
BRD | Director/Board Member | 74 | 17-06-12 |
Kevin Comcowich
CHM | Chairman | 55 | 16-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-16 | 1.92 | +1.59% | 16,070 |
24-04-15 | 1.89 | -3.57% | 6,366 |
24-04-12 | 1.96 | -0.75% | 2,786 |
24-04-11 | 1.975 | -2.72% | 39,212 |
24-04-10 | 2.03 | -0.49% | 6,939 |
Delayed Quote Nasdaq, April 17, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.15% | 2.62M | |
+11.71% | 37.26B | |
-.--% | 10.88B | |
-11.09% | 6.92B | |
+6.56% | 6.78B | |
-2.48% | 6.14B | |
-5.87% | 5.47B | |
+34.94% | 5.21B | |
-17.16% | 5.16B | |
+21.42% | 4.46B |
- Stock Market
- Equities
- RKDA Stock